Assessment of the scientific rigour of randomized controlled trials on the effectiveness of cognitive behavioural therapy and graded exercise therapy for patients with myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review. — CFSMEATLAS
Assessment of the scientific rigour of randomized controlled trials on the effectiveness of cognitive behavioural therapy and graded exercise therapy for patients with myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review.
Ahmed, S A, Mewes, J C, Vrijhoef, Hjm · Journal of health psychology · 2020 · DOI
Quick Summary
This review examined 18 previous studies that tested cognitive behavioural therapy (talk therapy focused on thoughts and behaviors) and graded exercise therapy (gradually increasing physical activity) for ME/CFS. The reviewers found that most of these studies had significant problems in how they were designed and conducted, which means we cannot be confident in their results. The review highlights that better, more carefully designed studies are needed with better ways of measuring improvements.
Why It Matters
This study is important because it questions the strength of evidence supporting two widely-recommended treatments for ME/CFS. For patients, it validates concerns that existing research may not be robust enough to prove these therapies work. For researchers, it identifies critical gaps in study design that must be addressed to generate trustworthy evidence about what treatments actually help ME/CFS patients.
Observed Findings
Bias was prominently identified across the 18 included studies
Primary outcome measures (fatigue, physical functioning, functional impairment/status) were significantly affected by methodological bias
Overall methodological quality of the studies was relatively low
Studies lacked objective outcome measures
Patient populations were not consistently well-defined across trials
Inferred Conclusions
Current evidence from RCTs on CBT and GET for ME/CFS cannot be considered scientifically rigorous due to pervasive bias and methodological limitations
Future research must include objective biomarkers rather than relying solely on subjective fatigue and functioning measures
Better definition and characterization of ME/CFS patient populations is essential for valid study design
The credibility of conclusions regarding the effectiveness of these treatments remains uncertain pending higher-quality research
Remaining Questions
What objective biological markers could be reliably used to measure treatment response in ME/CFS trials?
How should ME/CFS patient populations be standardized and defined in future research to ensure homogeneity?
What This Study Does Not Prove
This systematic review does not prove that CBT or GET are ineffective—it only shows the studies testing them have serious design flaws. The review does not determine whether properly-designed studies would show these therapies work or don't work. It assesses methodological quality, not true treatment efficacy.